Novel "digital-style" rapid test simultaneously detecting heart attack and predicting cardiovascular disease risk

Analytical Letters

Volumn 38, Issue 3, 2005, Pages 423-439

  Leung, Wingman ^a   Chan, Cangel Puiyee ^a   Leung, Manfai ^a   Renneberg, Reinhard ^a   Lehmann, Karin ^b   Renneberg, Ilka ^b   Lehmann, Matthias ^b   Hempel, Albrecht ^c   Glatz, Jan F C ^d  

^a HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

^b 8sensbiognostic AG   (Germany)

^c Heart Center Brandenburg   (Germany)

^d MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

C reactive protein (CRP); Cardiovascular disease risk; Digital style; Dipstick; Heart attack; Heart type fatty acid binding protein (H FABP); Myocardial infarction

Indexed keywords

C REACTIVE PROTEIN; FATTY ACID BINDING PROTEIN;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIAGNOSTIC TEST; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; IMMUNORADIOMETRIC ASSAY; MAJOR CLINICAL STUDY; MALE; QUANTITATIVE ANALYSIS; QUANTITATIVE ASSAY; RISK ASSESSMENT; VASCULAR ENDOTHELIUM;

EID: 16344383671     PISSN: 00032719     EISSN: None     Source Type: Journal    
DOI: 10.1081/AL-200045139     Document Type: Article

References (31)

1. Bland, J.M. and Altman, D.G. 1999. Measuring agreement in method comparison studies. Stat. Methods Med. Res., 8: 135-160.
2. Chan, C.P.Y. 2002. A superior early myocardial infarction marker-human heart-type fatty acid-binding protein, PhD thesis. Hong Kong: Hong Kong University of Science and Technology.
3. Chan, C.P.Y., Sanderson, J.E., Glatz, J.F.C., Cheng, W.S., Hempel, A., and Renneberg, R. 2004. A superior early myocardial infarction marker-human heart-type fatty acid-binding protein. Zeitschrift fur Kardiologie, 93: 1-10.
4. Chan, C.P.Y., Sum, K.W., Cheung, K.Y., Glatz, J.F.C., Sanderson, J.E., Hempel, A., Lehmann, M., Renneberg, I., and Renneberg, R. 2003. Development of a quantitative lateral-flow assay for rapid detection of fatty acid-binding protein. J. Immunol. Methods, 279: 91-100.
5. Claus, D.R., Osmand, A.P., and Gewurz, H. 1976. Radioimmunoassay of human C-reactive protein and levels in normal sera. J. Lab. Clin. Med., 87: 120-128.
6. Du Clos, T.W. 2000. Function of C-reactive protein. Ann. Med., 32: 274-278.
7. Gabay, C. and Kushner, I. 1999. Acute-phase proteins and other systemic responses to inflammation. N. Engl. J. Med., 340: 448-454.
8. Hutchinson, W.L., Koenig, W., Fröhlich, M., Sund, M., Lowe, G.D.O., and Pepys, M.B. 2000. Immunoradiometric assay of circulating C-reactive protein: Age-related values in the general population. Clin. Chem., 46: 934-938.
9. Kuller, L.H., Tracy, R.P., Shaten, J., and Meilahn, E.N. 1996. Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention Trial. Am. J. Epidemiol., 144: 537-547.
10. Ledue, T.B., Weiner, D.L., Sipe, J.D., Poulin, S.E., Collins, M.F., and Rifai, N. 1998. Analytical evaluation of particle-enhanced immunonephelornetric assays for C-reactive protein, serum amyloid A and mannose-binding protein in human serum. Ann. Clin. Biochem., 35: 745-753.
11. Meier-Ewert, H.K., Ridker, P.M., Rifai, N., Price, N., Dinges, D.F., and Mullington, J.M. 2001. Absence of diurnal variation of C-reactive protein concentrations in healthy human subjects. Clin. Chem., 47: 426-430.
12. National Committee for Clinical Laboratory Standards (NCCLS). 1986. Evaluation of the Linearity of Quantitative Analytical Methods; Proposed Guideline. NCCLS Publication EP6-P, Villanova, PA.
13. National Committee for Clinical Laboratory Standards (NCCLS). 1992. Evaluation of Precision Performance of Clinical Chemistry Devices. NCCLS Publication EP5-T2, Villanova, PA.
14. National Committee for Clinical Laboratory Standards (NCCLS). 1995. Method Comparison and Bias Estimation Using Patient Samples; Approved Guideline. NCCLS Publication EP9-A, Villanova, PA.
15. Osmand, A.P., Friedenson, B., Gewurz, H., Painter, R.H., Hofmann, T., and Shelton, E. 1977. Characterization of C-reactive protein and the complement subcomponent Clt as homologous proteins displaying cyclic pentameric symmetry (pentraxins). Proc. Natl. Acad. Sci. USA, 74: 739-745.
16. Pearson, T.A., Mensah, G.A., Alexander, R.W., Anderson, J.L., Cannon, R.O., and Criqui, M. 2003. Marker of Inflammation and cardiovascular disease. Application to healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation, 107: 499-511.
17. Peltola, H., Laipio, M.L., and Siimes, M.A. 1984. Quantitative C-reactive protein (CRP). Determination by an immunoturbidimetric method in rapid differential diagnosis of acute bacterial and viral diseases of children. Acta Paediatrica Scandinavia, 73: 273-274.
18. Pepys, M.B. 1981. C-reactive protein fifty years on. Lancet, 1: 653-658.
19. Ridker, P.M. 2003. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation, 107: 363-369.
20. Ridker, P.M., Buring, J.E., Shih, J., Matias, M., and Hennekens, C.H. 1998. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation, 98: 731-733.
21. Ridker, P.M., Cushman, M., Stampfer, M.J., Tracy, R.P., and Hennekens, C.H. 1997. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N. Engl. J. Med., 336: 973-979.
22. Ridker, P.M., Hennekens, C.H., Buring, J.E., and Rifai, N. 2000. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N. Engl. J. Med., 342 (12): 836-843.
23. Ridker, P.M., Rifai, N., Rose, L., Buring, J.E., and Cook, N.R. 2002. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N. Engl. J. Med., 347: 1557-1565.
24. Rifai, N., Tracy, R.P., and Ridker, P.M. 1999. Clinical efficacy of an automated high-sensitivity C-reactive protein assay. Clin. Chem., 45: 2136-2141.
25. Roberts, W.L., Moulton, L., Law, T.C., Farrow, G., Cooper-Anderson, M., and Savory, J. 2001. Evaluation of nine automated high-sensitivity C-reactive protein methods: Implications for clinical and epidemiological applications. Part 2. Clin. Chem., 47: 418-425.
26. Roberts, W.L., Sedrick, R., Moulton, L., Spencer, A., and Rifai, N. 2000. Evaluation of four automated high sensitivity C-reactive protein methods: implications for clinical and epidemiological applications. Clin. Chem., 46: 461-468.
27. Ross, R. 1999. Atherosclerosis: An inflammatory disease. N. Engl. J. Med., 340 (2): 115-126.
28. Rothkrantz-Kos, S., Schmitz, M.P.J., Bekers, B., Menheere, P.C.A., and Dieijen-Visser, P.V. 2002. High-Sensitivity C-reactive protein methods examined. Clin. Chem., 48: 359-362.
29. Tracy, R.P., Lemaitre, R.N., Psaty, B.M., Ives, D.G., Evans, R.W., and Cushman, M. 1997. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results of the Cardiovascular Health Study and the Rural Health Promotion Project. Arterioscler. Thromb. Vasc. Biol., 17: 1121-1127.
30. Volanakis, J.E. 2001. Review: Human C-reactive protein: Expression, structure, and the function. Molecular Immunol., 38: 189-197.
31. World Health Organization. 2003. World Health Report, 2003. Geneva, Switzerland: World Health Organization.